Patents by Inventor Rong Yang

Rong Yang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocycle-substituted Pyridyl Benzothiophenes as Kinase Inhibitors
    Publication number: 20160102081
    Abstract: This invention is directed to a compound of Formula I or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4 and X are as defined herein. The compounds of Formula I are useful as receptor tyrosine kinase (RTK) inhibitors and can be used to treat such diseases as cancer, blood vessel proliferative disorders, fibrotic disorders, mesangial cell proliferative disorders and metabolic diseases.
    Type: Application
    Filed: October 9, 2014
    Publication date: April 14, 2016
    Inventors: Sougato Boral, Thomas C. Malone, Shimiao Wang, Sandhya Rao, Rong Yang
  • PIPERIDYLPYRIMIDINE DERIVATIVES AS MODULATORS OF PROTEIN KINASE INHIBITORS AND OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2
    Publication number: 20160102088
    Abstract: This invention is directed to a compound of Formula I or a pharmaceutically acceptable salt thereof, wherein X, R1, R2, R3, R4, R5, R6 and R7 are as defined herein. The compounds of Formula I are useful as protein kinase (PK) inhibitors and can be used to treat such diseases as cancer, blood vessel proliferative disorders, fibrotic disorders, mesangial cell proliferative disorders, metabolic diseases inflammatory disorders and neurodegenerative disorders.
    Type: Application
    Filed: October 10, 2014
    Publication date: April 14, 2016
    Inventors: Julie A. Wurster, Thomas C. Malone, Clarence Eugene Hull, III, Sandhya Rao, Rong Yang, Richard Yee
  • Piperidylpyrimidine derivatives as modulators of protein kinase inhibitors and of vascular endothelial growth factor receptor 2
    Patent number: 9296747
    Abstract: This invention is directed to a compound of Formula I or a pharmaceutically acceptable salt thereof, wherein X, R1, R2, R3, R4, R5, R6 and R7 are as defined herein. The compounds of Formula I are useful as protein kinase (PK) inhibitors and can be used to treat such diseases as cancer, blood vessel proliferative disorders, fibrotic disorders, mesangial cell proliferative disorders, metabolic diseases inflammatory disorders and neurodegenerative disorders.
    Type: Grant
    Filed: October 10, 2014
    Date of Patent: March 29, 2016
    Assignee: Allergan, Inc.
    Inventors: Julie A. Wurster, Thomas C. Malone, Clarence Eugene Hull, III, Sandhya Rao, Rong Yang, Richard Yee
  • Reference power generating circuit and electronic circuit using the same
    Patent number: 9268348
    Abstract: A reference power generating circuit and an electronic circuit using the same are provided. The reference power generating circuit includes a first bandgap reference circuit and a second bandgap reference circuit. The first bandgap reference circuit is biased by a power voltage to generate a first reference voltage, where the first reference voltage has a first offset. The second bandgap reference circuit is connected to the first bandgap reference circuit in series and receives the first reference voltage generated by the first bandgap reference circuit. The second bandgap reference circuit is biased by the first reference voltage to generate a baseline reference voltage. The baseline reference voltage has a second offset, and the second offset is smaller than the first offset.
    Type: Grant
    Filed: May 26, 2014
    Date of Patent: February 23, 2016
    Assignee: Midastek Microelectronic Inc.
    Inventor: Muh-Rong Yang
  • Development of Zwitterionic Coatings that Confer Ultra Anti-Biofouling Properties to Commercial Reverse Osmosis Membranes
    Publication number: 20160002489
    Abstract: Disclosed are methods of preparing antifouling coatings on reverse osmosis membranes with initiated chemical vapor deposition. The coatings enhance the stability and lifetime of membranes without sacrificing performance characteristics, such as permeability or salt retention.
    Type: Application
    Filed: July 7, 2014
    Publication date: January 7, 2016
    Inventors: Karen K. Gleason, Zafarullah Khan, Hafiz Zahid Shafi, Rong Yang
  • Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
    Patent number: 9200016
    Abstract: The invention relates to compounds of the formula or a pharmaceutically acceptable salt thereof, wherein R?, R1 through R7 and Ar are as defined herein. These compounds are useful as inhibitors of phosphodiesterase 10 (PDE10A) which are useful in treating central nervous system diseases such as psychosis and also in treating, for example, obesity, type II diabetes, metabolic syndrome, glucose intolerance, pain and ophthalmic diseases.
    Type: Grant
    Filed: December 5, 2013
    Date of Patent: December 1, 2015
    Assignees: Allergan, Inc., Exonhit Therapeutics, SA
    Inventors: Bertrand Leblond, Thierry Taverne, Cedric Chauvignac, Eric Beausoleil, Anne-Sophie Casagrande, Laurent Desire, Matthew P. Pando, John E. Donello, Rong Yang
  • SMART POWER ADAPTOR AND METHOD FOR CONTROLLING POWER SUPPLAY THEREOF
    Publication number: 20150263638
    Abstract: A smart power adaptor and a method of controlling power supply thereof are provided. The smart power adaptor includes a power conversion circuit and a control unit. The power conversion circuit is configured to convert an alternating current (AC) power into a direct current (DC) power for providing to a load device. The control unit is coupled to the power conversion circuit. The control unit is configured to apply a corresponding power-supply control mean according to a power state through communication of a charging communication protocol of a battery module of the load device to control an operation of the power conversion circuit, so that the power conversion circuit uses different power conversion behaviors to generate the DC power in response to changing of the power status.
    Type: Application
    Filed: May 30, 2014
    Publication date: September 17, 2015
    Applicant: MIDASTEK MICROELECTRONIC INC.
    Inventor: Muh-Rong Yang
  • REFERENCE POWER GENERATING CIRCUIT AND ELECTRONIC CIRCUIT USING THE SAME
    Publication number: 20150261234
    Abstract: A reference power generating circuit and an electronic circuit using the same are provided. The reference power generating circuit includes a first bandgap reference circuit and a second bandgap reference circuit. The first bandgap reference circuit is biased by a power voltage to generate a first reference voltage, where the first reference voltage has a first offset. The second bandgap reference circuit is connected to the first bandgap reference circuit in series and receives the first reference voltage generated by the first bandgap reference circuit. The second bandgap reference circuit is biased by the first reference voltage to generate a baseline reference voltage. The baseline reference voltage has a second offset, and the second offset is smaller than the first offset.
    Type: Application
    Filed: May 26, 2014
    Publication date: September 17, 2015
    Applicant: MIDASTEK MICROELECTRONIC INC.
    Inventor: Muh-Rong Yang
  • Pointing device
    Patent number: 9110638
    Abstract: A pointing device includes an enclosure, a touch panel, and a securing panel. The enclosure includes an enclosure body, a first resisting portion and a second resisting portion extending from the enclosure body, and an elastic element mounted to the enclosure body. The touch panel is placed between the first resisting portion and the second resisting portion. The securing panel includes a panel body and a first resisting tab and a second resisting tab extending from the panel body. The first resisting tab is received in the first resisting portion, and the second resisting tab is received in the second resisting portion, thereby enabling the touch panel to be secured between the panel body and the enclosure body.
    Type: Grant
    Filed: June 26, 2013
    Date of Patent: August 18, 2015
    Assignees: HONG FU JIN PRECISION INDUSTRY (ShenZhen) CO., LTD., HON HAI PRECISION INDUSTRY CO., LTD.
    Inventors: Chih-Hao Yang, Xiang-Kun Zeng, Rong Yang, Dong-Xu Tan
  • TOPICAL RETINOID FORMULATIONS, PROCESSES FOR MAKING AND METHODS OF USE
    Publication number: 20150209342
    Abstract: The present invention provides topical dermal compositions including the compositions of the invention are useful for treating a variety of conditions associated with excess sebum production, such as, for example, acne.
    Type: Application
    Filed: January 28, 2015
    Publication date: July 30, 2015
    Inventors: Guang Wei Lu, Fangjing Wang, Shaoxin Feng, Hui Liu, Patrick Hughes, Scott Smith, Rong Yang
  • TOPICAL DERMAL COMPOSITIONS
    Publication number: 20150209343
    Abstract: The present invention provides topical dermal compositions useful for treating a variety of conditions associated with excess sebum production, such as for example acne.
    Type: Application
    Filed: January 28, 2015
    Publication date: July 30, 2015
    Inventors: Guang Wei Lu, Fangjing Wang, Kevin S. Warner, Rong Yang, Robert H. Mo
  • SUBSTITUTED 6, 7-DIALKOXY-3-ISOQUINOLINE DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE 10 (PDE 10A)
    Publication number: 20150158895
    Abstract: The invention relates to compounds of the formula or a pharmaceutically acceptable salt thereof, wherein R?, R1 through R7 and Ar are as defined herein. These compounds are useful as inhibitors of phosphodiesterase 10 (PDE10A) which are useful in treating central nervous system diseases such as psychosis and also in treating, for example, obesity, type II diabetes, metabolic syndrome, glucose intolerance, pain and ophthalmic diseases.
    Type: Application
    Filed: December 5, 2013
    Publication date: June 11, 2015
    Applicant: Allergan, Inc.
    Inventors: Bertrand Leblond, Thierry Taverne, Cedric Chauvignac, Eric Beausoleil, Anne-Sophie Casagrande, Laurent Desire, Matthew P. Pando, John E. Donello, Rong Yang
  • 14-HYDROXY-DOCOSAHEXAENOIC ACID COMPOUNDS
    Publication number: 20150119460
    Abstract: The invention describes novel 14-hydroxy docosahexaenoic acid (DHA) analogues, their preparation, isolation, identification, purification and uses thereof.
    Type: Application
    Filed: December 1, 2014
    Publication date: April 30, 2015
    Inventors: Charles N. SERHAN, Rong YANG
  • 14-HYDROXY-DOCOSAHEXAENOIC ACID COMPOUNDS
    Publication number: 20150119462
    Abstract: The invention describes novel 14-hydroxy docosahexaenoic acid (DHA) analogues, their preparation, isolation, identification, purification and uses thereof.
    Type: Application
    Filed: December 1, 2014
    Publication date: April 30, 2015
    Inventors: Charles N. SERHAN, Rong YANG
  • 14-HYDROXY-DOCOSAHEXAENOIC ACID COMPOUNDS
    Publication number: 20150119463
    Abstract: The invention describes novel 14-hydroxy docosahexaenoic acid (DHA) analogues, their preparation, isolation, identification, purification and uses thereof.
    Type: Application
    Filed: December 1, 2014
    Publication date: April 30, 2015
    Inventors: Charles N. SERHAN, Rong YANG
  • SHUTTLE VAN SYSTEM FOR CONTAINER TERMINAL AND METHOD FOR TRANSPORTING CONTAINERS USING SAME
    Publication number: 20150098776
    Abstract: A shuttle van system for a container terminal, including: at least one rail and a transfer device. The transfer device includes a plurality of shuttle vans and a plurality of transition platforms. Each shuttle van includes: a base frame, a wheel group, a wheel driving device, a lifting device, and a supporting plate. Each transition platform includes brackets. The shuttle vans run on the rail between the brackets. The lifting device of the shuttle van is configured to lift the container from the supporting plate. The container is transferred from the supporting plate of the shuttle van to the bracket after contraction of the lifting device.
    Type: Application
    Filed: December 15, 2014
    Publication date: April 9, 2015
    Inventors: Wei Li, Xun LI, Guoli AN, Lianyi ZHU, Qingxin LV, Rong YANG, Qiang LI
  • DOCOSAHEXAENOYL ETHANOLAMIDES
    Publication number: 20150025257
    Abstract: The invention describes novel mono or dihydroxy docosahexaenoic acid (DHA) analogues, their preparation, isolation, identification, purification and uses thereof.
    Type: Application
    Filed: June 8, 2012
    Publication date: January 22, 2015
    Applicant: The Brigham and Women's Hospital, Inc.
    Inventors: Charles N. Serhan, Rong Yang
  • 14-hydroxy-docosahexaenoic acid compounds
    Patent number: 8927747
    Abstract: The invention describes novel 14-hydroxy docosahexaenoic acid (DHA) analogs, their preparation, isolation, identification, purification and uses thereof.
    Type: Grant
    Filed: September 15, 2009
    Date of Patent: January 6, 2015
    Assignee: The Brigham and Women's Hospital, Inc.
    Inventors: Charles N. Serhan, Rong Yang
  • Chair
    Patent number: D730653
    Type: Grant
    Filed: January 14, 2014
    Date of Patent: June 2, 2015
    Inventor: Chun-Rong Yang
  • Chair
    Patent number: D734955
    Type: Grant
    Filed: July 11, 2014
    Date of Patent: July 28, 2015
    Inventor: Chun-Rong Yang